SAMRATPHPharmaceuticals
Samrat Pharmachem Ltd — Quarterly Results & Earnings
₹194.95
-7.93%
Profit Growth YoY-122.18%Latest quarter
Sales Growth YoY12.40%Latest quarter
Sales CAGR 5Y15.77%5 year compound
Profit CAGR 5Y10.15%5 year compound
📋
Quarterly Performance
YoY Profit Growth-122.18%
🔴 Significant decline
YoY Sales Growth+12.40%
✅ Strong growth
OPM 5Y Average
5.45%Operating profit margin
EPS Growth 5Y
10.15%Interest Coverage
3.95Higher = safer debt servicing
ROE
10.07%ROCE
13.21%💡
Growth Analysis
Samrat Pharmachem Ltd reported YoY profit growth of -122.18% and revenue growth of 12.40% in the latest quarter. Significant profit decline — requires close monitoring. Over 5 years, sales compounded at 15.77% and profits at 10.15% annually. This is above-average growth for Indian listed companies. Consistent growth over 4-8 quarters is more meaningful than any single quarter. Educational data only.
More on Samrat Pharmachem Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.